Patients who experience a nonaneurysmal subarachnoid hemorrhage differ from patients who suffer an aneurysmal subarachnoid hemorrhage in initial presentation (including neurological examination ...

The following is a summary of “Liberal versus restrictive transfusion strategies in subarachnoid hemorrhage: a secondary ...

Subarachnoid hemorrhage (SAH) is often followed by fever. The rise in brain temperature can lead to ischemic brain injury, hyperemia, exacerbation of cerebral edema, and increased intracranial ...

Background. Acute non-traumatic focal subarachnoid haemorrhage (fSAH) is a rare transient ischaemic attack (TIA)-mimic. MRI is considered to be indispensable by some authors in order to avoid ...

A subarachnoid hemorrhage was demonstrated on a head CT scan. Investigations. Physical examination, laboratory tests, brain CT scan, brain MRI scan, brain magnetic resonance angiogram, brain ...

Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission ...

Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine. New Drug Application (NDA) Submission Expected in the ...

Financing led by Nantahala Capital and ADAR1 Partners, LP with participation from new and existing healthcare-focused institutional investors$15 ...

PRINCETON, N.J. - Grace Therapeutics, Inc. (NASDAQ:GRCE), a biopharmaceutical company focused on developing treatments for ...

Cerebrospinal fluid flows less effectively for up to 12 months after a subarachnoid hemorrhage, according to a new Norwegian study.